Enasidenib (Idhifa)

enasidenib · Celgene/BMS

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Enasidenib (Idhifa), covering 2024-10-02 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation [Phase 1, Phase 2]